Other and Unspecified Pancreas
Primary Site | Histology | Staging Type |
---|---|---|
C253-C254, C257-C259 | 8000-8576, 8940-8950, 8971, 8980-8981 | TNM 7 and Summary Stage |
C253-C254, C257-C259 | 8577-8939, 8951-8970, 8972-8979, 8982-9136, 9141-9582, 9700-9701 | Summary Stage only |
If you are working with a site/histology that only summary stages and you need to directly code it, please use the SEER Summary Stage 2000 manual
Notes
C253 Pancreatic duct C254 Islets of Langerhans C257 Other specified parts of pancreas C258 Overlapping lesion of pancreas C259 Pancreas, NOS **Note 1:** This schema is based on the UICC chapter *Pancreas,* pages 132-135. * Primary sites C257, C258 and C259 are not listed in this chapter of the UICC manual; however, they are included in this schema and TNM staged if appropriate histology criteria are met **Note 2:** For tumors of the islet cells, determine which subsite of the pancreas is involved and use that primary site code and the corresponding schema. * If the subsite cannot be determined, use the general code for Islets of Langerhans, C254, and use the schema for Pancreas, Other and Unspecified **Note 3:** In addition to directly assigning TNM, Summary Stage 2000 (SS2000) must be captured. If directly assigning SS2000, use the *Pancreas: Other and Unspecified* chapter on page 120 of the [SS2000 on-line manual](http://seer.cancer.gov/tools/ssm/SSSM2000-122012.pdf#page=120).Main Data Items
Name | Default Value | Used for Staging | NAACCR Item | Required By | Metadata |
---|---|---|---|---|---|
Clinical T | <BLANK> | Yes | NAACCR #940 | None | |
Clinical N | <BLANK> | Yes | NAACCR #950 | None | |
Clinical M | <BLANK> | Yes | NAACCR #960 | None | |
TNM Clin Stage Group | 99 | Yes | NAACCR #970 | None | |
Pathologic T | <BLANK> | Yes | NAACCR #880 | None | |
Pathologic N | <BLANK> | Yes | NAACCR #890 | None | |
Pathologic M | <BLANK> | Yes | NAACCR #900 | None | |
TNM Path Stage Group | 99 | Yes | NAACCR #910 | None | |
SSF1: Carbohydrate Antigen 19-9 (CA 19-9) Lab Value | 988 | No | NAACCR #2880 | None | None |
SSF2: Serum Chromogranin A (CgA) Lab Value | 988 | No | NAACCR #2890 | None | None |
SSF3: Mitotic Count | 988 | No | NAACCR #2900 | None | None |
Additional Data Items
Name | Default Value | Used for Staging | NAACCR Item | Required By | Metadata |
---|---|---|---|---|---|
Year of Diagnosis | <BLANK> | No | NAACCR #390 | None | |
Primary Site | <BLANK> | Yes | NAACCR #400 | None | |
Histology | <BLANK> | Yes | NAACCR #522 | None | |
Behavior | <BLANK> | Yes | NAACCR #523 | None | |
RX Summ Systemic/Surgery Sequence | <BLANK> | Yes | NAACCR #1639 | None | |
RX Summ Surgery/Radiation Sequence | <BLANK> | Yes | NAACCR #1380 | None | |
Regional Nodes Positive | <BLANK> | Yes | NAACCR #820 | None |
Initial Context
Outputs
Name | Default Value | Description | NAACCR Item | Metadata |
---|---|---|---|---|
Derived Version | 1.2 | None | None | |
Derived SEER Clin Stage Group | 88 |
NAACCR #3610
None |
None | |
Derived SEER Path Stage Group | 88 |
NAACCR #3605
None |
None | |
Derived SEER Combined Stage Group | 88 |
NAACCR #3614
None |
None | |
Derived SEER Combined T | 88 |
NAACCR #3616
None |
None | |
Derived SEER Combined N | 88 |
NAACCR #3618
None |
None | |
Derived SEER Combined M | 88 |
NAACCR #3620
None |
None | |
Derived SEER Combined T Source | <BLANK> |
NAACCR #3622
None |
None | |
Derived SEER Combined N Source | <BLANK> |
NAACCR #3624
None |
None | |
Derived SEER Combined M Source | <BLANK> |
NAACCR #3626
None |
None |